RAPID AND SUSTAINED IMPROVEMENT IN SLEEP QUALITY, ANXIETY, AND DEPRESSION IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB TREATMENT

被引：0
|
作者：
Merola, Joseph F. [1 ]
Chiou, Albert S. [2 ]
During, Emmanuel [2 ]
Foley, Peter [3 ]
Ardeleanu, Marius [4 ]
Wu, Jiangming [5 ]
Ozturk, Zafer E. [6 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[2] Stanford Univ, Palo Alto, CA USA
[3] Skin Hlth Inst, Carlton, Vic, Australia
[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[5] Sanofi, Bridgewater, NJ USA
[6] Sanofi, Cambridge, MA USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P8.23
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [31] Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein
    Gooderham, Melinda
    Pariser, David M.
    Simpson, Eric L.
    Etoh, Takafumi
    Chen, Zhen
    Sierka, Debra
    Shumel, Brad
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB118 - AB118
  • [32] Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks
    Blauvelt, A.
    Bieber, T.
    de Bruin-Weller, M.
    Gooderham, M.
    Pariser, D. M.
    Simpson, E. L.
    Etoh, T.
    Bastian, M.
    Chen, Z.
    Sierka, D.
    Levit, N. A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 66 - 66
  • [33] Dupilumab provides early and sustained improvement of sleep disturbance in children ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Simpson, E. L.
    Hong, H. C.
    Marcoux, D.
    Chen, Z.
    Bego-Le Bagousse, G.
    Wang, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E121 - E122
  • [34] Dupilumab provides early and sustained improvement of sleep disturbance in children ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, Amy S.
    Simpson, Eric L.
    Beck, Lisa A.
    Hong, H. Chih-Ho
    Marcoux, Danielle
    Chen, Zhen
    Shumel, Brad
    Bansal, Ashish
    Rossi, Ana B.
    Chao, Jingdong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB139 - AB139
  • [35] Treatment satisfaction in patients receiving dupilumab for moderate-to-severe atopic dermatitis
    Lans, A.
    Van der Schaft, J.
    Bakker, D.
    Ariens, L.
    Thijs, J. H.
    De Bruin-Weller, M. S.
    Balak, D. M. W.
    ALLERGY, 2019, 74 : 82 - 82
  • [36] Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate-to-severe atopic dermatitis
    Miniotti, Marco
    Lazzarin, Giulia
    Ortoncelli, Michela
    Mastorino, Luca
    Ribero, Simone
    Leombruni, Paolo
    DERMATOLOGIC THERAPY, 2022, 35 (05)
  • [37] Dupilumab significantly improves sleep disturbance in adults with moderate-to-severe atopic dermatitis: Results of the DUPISTAD study
    Merola, Joseph F.
    Chiou, Albert S.
    During, Emmanuel
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB46 - AB46
  • [38] Dupilumab treatment for up to 100 weeks demonstrates sustained improvement in quality of life in adult patients with moderate-to-severe atopic dermatitis (LIBERTY AD OLE)
    Thaci, D.
    Deleuran, M.
    De Bruin-Weller, M.
    Chen, Z.
    Tomondy, P.
    Ardeleanu, M.
    Boklage, S.
    Shumel, B.
    Surendranathan, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 12 - 13
  • [39] Dupilumab monotherapy for 1 year provides sustained improvement in Dermatology Life Quality Index in adults with moderate-to-severe atopic dermatitis optimally responding at week 16
    Bagel, J.
    Marron, S. E.
    Lacour, J. -P.
    Pinter, A.
    Romanelli, M.
    Hong, C. -H.
    Mitsui, H.
    Park, C. W.
    Zhang, H.
    Thomas, R. B.
    Bego-Le Bagousse, G.
    Wortzman-Show, G.
    Rossi, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E160 - E160
  • [40] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
12345